Myocardial performance index after surgical correction of ventricular septal defects

Yasser Baghdady1, Yasser Kamel, Waleed Amar

  • 1Cardiology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.

Insights

Myocardial Performance Index (MPI) effectively assesses ventricular function after VSD surgery, correlating with ejection fraction and predicting patient recovery outcomes.

Area of Science:

  • Cardiology
  • Pediatric Surgery
  • Echocardiography

Background:

  • Myocardial Performance Index (MPI) is a non-invasive Doppler measurement of ventricular function.
  • Ventricular Septal Defect (VSD) surgical correction requires assessment of postoperative recovery.

Purpose of the Study:

  • To assess MPI in children post-VSD surgical correction.
  • To evaluate MPI's impact on postoperative recovery.

Main Methods:

  • Prospective study of 30 children undergoing VSD repair.
  • Comparison with a control group of 30 healthy children.
  • Assessment of right and left ventricular MPI, ejection fraction (EF), fractional shortening (FS), and left ventricular end-diastolic diameter (LVEDD).

Main Results:

  • Both RV and LV MPI correlated significantly with EF.
  • MPI positively correlated with LVEDD, VSD size, ventilation duration, inotropic support, and ICU stay.
  • Pre-surgery and post-surgery MPI, along with EF, predicted VSD surgery outcomes.

Conclusions:

  • MPI is a valuable tool for measuring left and right ventricular function post-VSD repair.
  • MPI correlates with key echocardiographic parameters and VSD size.
  • MPI significantly predicts VSD surgery outcomes.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...